Cardiac Wire #252 March 6, 2025
Independent CV Board Rejected | First Living MVR
Cardiac Wire #251 March 3, 2025
Finerenone’s Diuretic Impact | Kestra’s IPO
Cardiac Wire #250 February 27, 2025
TAVR Valve Tie | VADs for Child CHD
Cardiac Wire #249 February 24, 2025
ATTR-CM Segment Heats Up | Aspartame & Insulin
Cardiac Wire #248 February 20, 2025
Shunts Help HF? | Olpasiran vs. OxPLs
Cardiac Wire #247 February 18, 2025
Atria’s PE Alternative | SCD/MVA Genes
Cardiac Wire #246 February 13, 2025
Novartis Acquires Anthos | COVID’s Heart Risks
Cardiac Wire #245 February 10, 2025
TAVR’s Weekend Effect | SAVR/CABG Advantage
Cardiac Wire #244 February 6, 2025
Lowering Elderly LDL-C | Merck Halts HYPERION
Cardiac Wire #243 February 3, 2025
Increasing CVD Burdens | New Lp(a) Test
Cardiac Wire #242 January 30, 2025
Mechanical AVR Still Matters | Neko’s Full-Body Fundraise
Cardiac Wire #241 January 27, 2025
Abelacimab’s Stroke Uncertainty | Keros Quits TROPOS
Cardiac Wire #240 January 23, 2025
GLP-1 Side Effects | CABG Guideline Debate
Cardiac Wire #239 January 16, 2025
Further Finerenone Findings | Canary’s Potential Obesity Cure
Cardiac Wire #238 January 13, 2025
AI-CCTA Beats SPECT | Coffee’s Heart Benefits
Cardiac Wire #237 January 9, 2025
AI-ECG’s Strong Start | VARIPULSE’s Stroke Scare
Cardiac Wire #236 January 6, 2025
Cardiac Imaging Medicare Scheme | Great Vessels, Great Outcomes
Cardiac Wire #235 December 19, 2024
Challenging CHAGASICS | Merck’s New GLP-1
Cardiac Wire #234 December 16, 2024